114 related articles for article (PubMed ID: 2484277)
1. Factors affecting 1H NMR spectra of blood plasma: cancer, diet and freezing.
Bell JD; Brown JC; Norman RE; Sadler PJ; Newell DR
NMR Biomed; 1988 Apr; 1(2):90-4. PubMed ID: 2484277
[TBL] [Abstract][Full Text] [Related]
2. 1H NMR studies of human blood plasma. Assignment of resonances for lipoproteins.
Bell JD; Sadler PJ; Macleod AF; Turner PR; La Ville A
FEBS Lett; 1987 Jul; 219(1):239-43. PubMed ID: 3595877
[TBL] [Abstract][Full Text] [Related]
3. Assignment of resonances for 'acute-phase' glycoproteins in high resolution proton NMR spectra of human blood plasma.
Bell JD; Brown JC; Nicholson JK; Sadler PJ
FEBS Lett; 1987 May; 215(2):311-5. PubMed ID: 2438159
[TBL] [Abstract][Full Text] [Related]
4. Maternal and cord blood plasma. Comparative analyses by 1H NMR spectroscopy.
Bell JD; Brown JC; Sadler PJ; Garvie D; Macleod AF; Lowy C
NMR Biomed; 1989 Jul; 2(2):61-5. PubMed ID: 2484279
[TBL] [Abstract][Full Text] [Related]
5. [H-NMR spectroscopy of plasma cannot be used for cancer screening].
Tran Dinh S; Schlumberger M; Gicquel C; Neumann JM; Hervé M; Turpin G; Parmentier C
Bull Cancer; 1988; 75(8):795-800. PubMed ID: 3179513
[TBL] [Abstract][Full Text] [Related]
6. Relationships between the proton nuclear magnetic resonance properties of plasma lipoproteins and cancer.
Otvos JD; Jeyarajah EJ; Hayes LW; Freedman DS; Janjan NA; Anderson T
Clin Chem; 1991 Mar; 37(3):369-76. PubMed ID: 2004443
[TBL] [Abstract][Full Text] [Related]
7. A lineshape fitting model for 1H NMR spectra of human blood plasma.
Hiltunen Y; Ala-Korpela M; Jokisaari J; Eskelinen S; Kiviniitty K; Savolainen M; Kesäniemi YA
Magn Reson Med; 1991 Oct; 21(2):222-32. PubMed ID: 1745121
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the metabolic profiles of fetal and maternal plasma and placenta in normal and diabetic rats by 1H magnetic resonance spectroscopy.
Brooks KJ; Lowy C; Thomas CR
Diabetes Res; 1994; 26(3):117-25. PubMed ID: 7621618
[TBL] [Abstract][Full Text] [Related]
9. Detection of malignant tumors: water-suppressed proton nuclear magnetic resonance spectroscopy of plasma.
Dowd TL; Kaplan BA; Gupta RK; Aisen P
Magn Reson Med; 1987 Oct; 5(4):395-7. PubMed ID: 3683172
[TBL] [Abstract][Full Text] [Related]
10. Proton nuclear magnetic resonance methyl and methylene linewidths from plasma decrease during postprandial lipemia.
Verdery RB; Benham DF; McLennan I; Busby MJ; Wehrle JP; Glickson JD
Biochim Biophys Acta; 1989 Dec; 1006(3):287-90. PubMed ID: 2597673
[TBL] [Abstract][Full Text] [Related]
11. High resolution proton NMR investigations of rat blood plasma. Assignment of resonances for the molecularly mobile carbohydrate side-chains of 'acute-phase' glycoproteins.
Grootveld M; Claxson AW; Chander CL; Haycock P; Blake DR; Hawkes GE
FEBS Lett; 1993 May; 322(3):266-76. PubMed ID: 7683613
[TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance spectroscopy of fractionated plasma lipoproteins and reconstituted plasma from healthy subjects and patients with cancer.
Engan T; Bjerve KS; Høe AL; Krane J
Scand J Clin Lab Invest; 1992 Sep; 52(5):393-408. PubMed ID: 1514018
[TBL] [Abstract][Full Text] [Related]
13. The NMR blood test for cancer: current status.
Fossel ET
Cancer Cells; 1991 May; 3(5):173-82. PubMed ID: 1654067
[TBL] [Abstract][Full Text] [Related]
14. Some factors that influence the plasma lipoprotein 1H NMR spectra of normal and cancer patients: an oncolipid test?
Lim HM; Price TB; Marsh JC; Rainey PM; Gore JC; Armitage IM
Yale J Biol Med; 1991; 64(1):63-77. PubMed ID: 1897263
[TBL] [Abstract][Full Text] [Related]
15. Quantitative In-Vitro Diagnostic NMR Spectroscopy for Lipoprotein and Metabolite Measurements in Plasma and Serum: Recommendations for Analytical Artifact Minimization with Special Reference to COVID-19/SARS-CoV-2 Samples.
Loo RL; Lodge S; Kimhofer T; Bong SH; Begum S; Whiley L; Gray N; Lindon JC; Nitschke P; Lawler NG; Schäfer H; Spraul M; Richards T; Nicholson JK; Holmes E
J Proteome Res; 2020 Nov; 19(11):4428-4441. PubMed ID: 32852212
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance spectroscopy of blood plasma lipoproteins in malignant disease: methodological aspects and clinical relevance.
Engan T
Anticancer Res; 1996; 16(3B):1461-71. PubMed ID: 8694514
[TBL] [Abstract][Full Text] [Related]
17. Two-dimensional 1H NMR spectroscopy of normal and pathological human plasma: complete water suppression and further assignment of resonances.
Kriat M; Confort-Gouny S; Vion-Dury J; Viout P; Cozzone PJ
Biochimie; 1992; 74(9-10):913-8. PubMed ID: 1334700
[TBL] [Abstract][Full Text] [Related]
18. 1H NMR studies on human plasma lipids from newborn infants, healthy adults, and adults with tumors.
Eskelinen S; Hiltunen Y; Jokisaari J; Virtanen S; Kiviniitty K
Magn Reson Med; 1989 Jan; 9(1):35-8. PubMed ID: 2540395
[TBL] [Abstract][Full Text] [Related]
19. NMR-invisible lactate in blood plasma.
Bell JD; Brown JC; Kubal G; Sadler PJ
FEBS Lett; 1988 Aug; 235(1-2):81-6. PubMed ID: 3402603
[TBL] [Abstract][Full Text] [Related]
20. 1H NMR metabonomics of plasma lipoprotein subclasses: elucidation of metabolic clustering by self-organising maps.
Suna T; Salminen A; Soininen P; Laatikainen R; Ingman P; Mäkelä S; Savolainen MJ; Hannuksela ML; Jauhiainen M; Taskinen MR; Kaski K; Ala-Korpela M
NMR Biomed; 2007 Nov; 20(7):658-72. PubMed ID: 17212341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
